These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
404 related articles for article (PubMed ID: 32445026)
1. Novel Therapies in the Treatment of Adult Acute Lymphoblastic Leukemia. Gavralidis A; Brunner AM Curr Hematol Malig Rep; 2020 Aug; 15(4):294-304. PubMed ID: 32445026 [TBL] [Abstract][Full Text] [Related]
2. Advances in Supportive Care for Acute Lymphoblastic Leukemia. Cook J; Litzow M Curr Hematol Malig Rep; 2020 Aug; 15(4):276-293. PubMed ID: 32607955 [TBL] [Abstract][Full Text] [Related]
3. Hematopoietic Cell Transplantation for Philadelphia Chromosome Negative Adult Acute Lymphoblastic Leukemia in the Modern Era of Immune Therapy. Yurkiewicz I; Craig J; Muffly L Curr Hematol Malig Rep; 2020 Jun; 15(3):187-193. PubMed ID: 32358681 [TBL] [Abstract][Full Text] [Related]
4. The ABCs of Immunotherapy for Adult Patients With B-Cell Acute Lymphoblastic Leukemia. Horvat TZ; Seddon AN; Ogunniyi A; King AC; Buie LW; Daley RJ Ann Pharmacother; 2018 Mar; 52(3):268-276. PubMed ID: 29025266 [TBL] [Abstract][Full Text] [Related]
5. Treatment with anti CD19 chimeric antigen receptor T cells after antibody-based immunotherapy in adults with acute lymphoblastic leukemia. Danylesko I; Chowers G; Shouval R; Besser MJ; Jacoby E; Shimoni A; Nagler A; Avigdor A Curr Res Transl Med; 2020 Jan; 68(1):17-22. PubMed ID: 31882377 [TBL] [Abstract][Full Text] [Related]
10. Incorporating Immunotherapy Into the Treatment Strategies of B-Cell Adult Acute Lymphoblastic Leukemia: The Role of Blinatumomab and Inotuzumab Ozogamicin. Kantarjian H; Jabbour E Am Soc Clin Oncol Educ Book; 2018 May; 38():574-578. PubMed ID: 30231308 [TBL] [Abstract][Full Text] [Related]
11. [Not Available]. Feuchtinger T Drug Res (Stuttg); 2018 Nov; 68(S 01):S12-S13. PubMed ID: 30453365 [No Abstract] [Full Text] [Related]
12. SOHO State of the Art Update and Next Questions: Advances in the Treatment of Adult Acute Lymphoblastic Leukemia. Paul S; Rausch CR; Welch MA; Kantarjian HM; Jabbour EJ Clin Lymphoma Myeloma Leuk; 2019 Aug; 19(8):471-479. PubMed ID: 31307896 [TBL] [Abstract][Full Text] [Related]
13. Treatment of Aggressive B Cell Lymphomas: Updates in 2019. Mondello P; Nowakowski GS Curr Hematol Malig Rep; 2020 Jun; 15(3):225-234. PubMed ID: 32372238 [TBL] [Abstract][Full Text] [Related]
14. Antibody based therapy in relapsed acute lymphoblastic leukemia. Jammal N; Chew S; Jabbour E; Kantarjian H Best Pract Res Clin Haematol; 2020 Dec; 33(4):101225. PubMed ID: 33279181 [TBL] [Abstract][Full Text] [Related]
15. Sequencing of novel agents in relapsed/refractory B-cell acute lymphoblastic leukemia: Blinatumomab and inotuzumab ozogamicin may have comparable efficacy as first or second novel agent therapy in relapsed/refractory acute lymphoblastic leukemia. Badar T; Szabo A; Dinner S; Liedtke M; Burkart M; Shallis RM; Yurkiewicz IR; Kuo E; Khan MA; Balasubramanian S; Yang J; Hefazi M; Podoltsev N; Patel A; Curran E; Wang A; Arslan S; Aldoss I; Siebenaller C; Mattison RJ; Litzow MR; Wadleigh M; Advani AS; Atallah E Cancer; 2021 Apr; 127(7):1039-1048. PubMed ID: 33259056 [TBL] [Abstract][Full Text] [Related]
16. How I treat adults with advanced acute lymphoblastic leukemia eligible for CD19-targeted immunotherapy. Aldoss I; Forman SJ Blood; 2020 Mar; 135(11):804-813. PubMed ID: 31899793 [TBL] [Abstract][Full Text] [Related]
18. Kinetics of immune reconstitution after anti-CD19 chimeric antigen receptor T cell therapy in relapsed or refractory acute lymphoblastic leukemia patients. Wang Y; Li H; Song X; Qi K; Cheng H; Cao J; Shi M; Yan Z; Jing G; Pan B; Sang W; Wang X; Zhao K; Chen C; Chen W; Zheng J; Li Z; Xu K Int J Lab Hematol; 2021 Apr; 43(2):250-258. PubMed ID: 33112046 [TBL] [Abstract][Full Text] [Related]
19. Chemoimmunotherapy with inotuzumab ozogamicin combined with mini-hyper-CVD, with or without blinatumomab, is highly effective in patients with Philadelphia chromosome-negative acute lymphoblastic leukemia in first salvage. Jabbour E; Sasaki K; Ravandi F; Huang X; Short NJ; Khouri M; Kebriaei P; Burger J; Khoury J; Jorgensen J; Jain N; Konopleva M; Garcia-Manero G; Kadia T; Cortes J; Jacob J; Montalbano K; Garris R; O'Brien S; Kantarjian HM Cancer; 2018 Oct; 124(20):4044-4055. PubMed ID: 30307611 [TBL] [Abstract][Full Text] [Related]